Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.8mm RC, SLA? 8mm, TiZr, NTP: medical device reports filed with FDA

5,448 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

5,448
device reports naming the brand
0% of all MAUDE reports · about 798 a year
749
reports, 12 months to August 2026
921 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

5,448 medical device reports received by FDA name the brand "BL, ? 4.8mm RC, SLA? 8mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

749 reports arrived in the 12 months to August 2026, down 19% from 921 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (61.3%), loss of osseointegration (30%) and difficult to insert (1.2%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

093185Sep 2021: 51Oct 2021: 55Nov 2021: 73Dec 2021: 392022Jan 2022: 47Feb 2022: 43Mar 2022: 58Apr 2022: 72May 2022: 81Jun 2022: 61Jul 2022: 42Aug 2022: 64Sep 2022: 74Oct 2022: 58Nov 2022: 59Dec 2022: 702023Jan 2023: 83Feb 2023: 48Mar 2023: 69Apr 2023: 76May 2023: 79Jun 2023: 72Jul 2023: 61Aug 2023: 85Sep 2023: 79Oct 2023: 83Nov 2023: 62Dec 2023: 602024Jan 2024: 72Feb 2024: 54Mar 2024: 57Apr 2024: 75May 2024: 95Jun 2024: 58Jul 2024: 83Aug 2024: 89Sep 2024: 74Oct 2024: 110Nov 2024: 76Dec 2024: 852025Jan 2025: 60Feb 2025: 54Mar 2025: 90Apr 2025: 33May 2025: 0Jun 2025: 185Jul 2025: 77Aug 2025: 77Sep 2025: 60Oct 2025: 65Nov 2025: 56Dec 2025: 732026Jan 2026: 64Feb 2026: 49Mar 2026: 62Apr 2026: 73May 2026: 68Jun 2026: 60Jul 2026: 71Aug 2026: 48

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

04649282019: 47320192020: 53320202021: 60320212022: 72920222023: 85720232024: 92820242025: 83020252026: 4952026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%5,448
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report77.9%4,242
Voluntary report0%0
User facility report0%0
Distributor report22.1%1,206
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate3,34061.3%62.8%
Loss of osseointegration1,63230%22.4%
Difficult to insertthe device was hard to insert681.2%0.4%
Fracturea broken bone160.3%1.6%
Separation failure90.2%0.1%
Unintended movement70.1%0%
Difficult to removethe device was hard to remove60.1%0%
Unstable60.1%0%
Therapeutic or diagnostic output failure10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,96236%
Painpain, site not specified1,18921.8%
Tissue damage65912.1%
Inflammationinflammation4117.5%
Hemorrhage/blood loss/bleeding3205.9%
Swelling/ edema3035.6%
Abscessa collection of pus1623%
Fistula1592.9%
Hyperresponsive to stimuli1272.3%
Sinus perforation951.7%
Hypersensitivity/allergic reaction430.8%
Failure of implant300.6%
Swellingswelling280.5%
Inadequate osseointegration130.2%
Increased sensitivity110.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.8mm RC, SLA? 8mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports5,4483,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer77.9%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.8mm RC, SLA? 8mm, TiZr, NTP reports

How many FDA reports name BL, ? 4.8mm RC, SLA? 8mm, TiZr, NTP?

5,448 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 749 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (61.3%), loss of osseointegration (30%), difficult to insert (1.2%), fracture (0.3%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (77.9%) and distributor reports (22.1%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.8mm RC, SLA? 8mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.